812
Views
19
CrossRef citations to date
0
Altmetric
Articles

Smart polymers for colon targeted drug delivery systems: a review

, &
Pages 1130-1166 | Received 02 Mar 2020, Accepted 17 Jun 2020, Published online: 09 Jul 2020

References

  • Ciftci, K. Alternative Approaches to the Treatment of Colon Cancer. Eur. J. Pharm. Biopharm. 1996, 42, 160–170.
  • Hanuer, S. B. Inflammatory Bowel Disease. N. Engl. J. Med. 1996, 334, 841–848.
  • Chourasia, M. K.; Jain, S. K. Polysaccharides for Colon Targeted Drug Delivery. Drug Deliv. 2004, 11, 129–148. doi:10.1080/10717540490280778.
  • Chourasia, M. K.; Jain, S. K. Pharmaceutical Approaches to Colon Targeted Drug Delivery Systems. J. Pharm. Pharm. Sci. 2003, 6, 33–66.
  • Lengyel, M.; Kállai-Szabó, N.; Antal, V.; Laki, A. J.; Antal, I. Microparticles, Microspheres, and Microcapsules for Advanced Drug Delivery. Sci. Pharm. 2019, 87, 20–31. doi:10.3390/scipharm87030020.
  • Philip, A. K.; Philip, B. Colon Targeted Drug Delivery Systems: A Review on Primary and Novel Approaches. Oman Med. J. 2010, 25, 79–87. doi:10.5001/omj.2010.24.
  • Shukla, R. K.; Tiwari, A. Carbohydrate Polymers: Applications and Recent Advances in Delivering Drugs to the Colon. Carbohyd. Polym. 2012, 88, 399–416. doi:10.1016/j.carbpol.2011.12.021.
  • Amidon, S.; Brown, J. E.; Dave, V. S. Colon-Targeted Oral Drug Delivery Systems: Design Trends and Approaches. AAPS PharmSciTech 2015, 16, 731–741. doi:10.1208/s12249-015-0350-9.
  • Gupta, A.; Mittal, A.; Gupta, A. K. Colon Targeted Drug Delivery Systems-A Review. Rus. J. Biopharm. 2011, 3, 3–13.
  • Sangeetha, G.; Begum, M. J.; Reddemma, S.; Rajendra, Y. Colon Targeted Drug Delivery System: A Review. Int. J. Pharm. Technol. 2011, 3, 1657–1672.
  • Vassallo, M.; Camilleri, M.; Phillips, S. F.; Brown, M. L.; Chapman, N. J.; Thomforde, G. M. Transit through the Proximal Colon Influences Stool Weight in the Irritable Bowel Syndrome. Gastroenterology 1992, 102, 102–108. doi:10.1016/0016-5085(92)91789-7.
  • Reddy, S. N.; Bazzocchi, G.; Chan, S.; Akashi, K.; Villanueva-Meyer, J.; Yanni, G.; Mena, I.; Snape, W. J. Jr. Colonic Motility and Transit in Health and Ulcerative Colitis. Gastroenterology 1991, 101, 1289–1297. doi:10.1016/0016-5085(91)90079-Z.
  • Yang, L.; Chu, J. S.; Fix, J. A. Colon-Specific Drug Delivery: New Approaches and In Vitro/In Vivo Evaluation. Int. J. Pharm. 2002, 235, 1–15. doi:10.1016/S0378-5173(02)00004-2.
  • Rubinstein, A. Natural Polysaccharides as Targeting Tools of Drugs to the Human Colon. Drug Dev. Res. 2000, 50, 435–439. doi:10.1002/1098-2299(200007/08)50:3/4<435::AID-DDR26>3.0.CO;2-5.
  • Rubinstein, A. Microbially Controlled Drug Delivery to the Colon. Biopharm. Drug Dispos. 1990, 11, 465–475. doi:10.1002/bdd.2510110602.
  • Kinget, R.; Kalala, W.; Vervoort, L.; Mooter, G. U. Colonic Drug Targeting. J. Drug Target. 1998, 6, 129–149. doi:10.3109/10611869808997888.
  • Saffran, M.; Kumar, G. S.; Savariar, C.; Burnham, J. C.; Williams, F.; Neckers, D. C. A New Approach to the Oral Administration of Insulin and Other Peptide Drugs. Science 1986, 233, 1081–1084. doi:10.1126/science.3526553.
  • Shantha, K. L.; Ravichandran, P.; Rao, K. P. Azo Polymeric Hydrogels for Colon Targeted Drug Delivery. Biomaterials 1995, 16, 1313–1318. doi:10.1016/0142-9612(95)91046-2.
  • Lee, S. H.; Bajracharya, R.; Min, J. Y.; Han, J. W.; Park, B. J.; Han, H. K. Strategic Approaches for Colon Targeted Drug Delivery: An Overview of Recent Advancements. Pharmaceutics 2020, 12, 68–20. doi:10.3390/pharmaceutics12010068.
  • Sarangi, M. K.; Rao, M. E. B.; Parcha, V.; Upadhyay, A. Tailoring of Colon Targeting with Sodium alginate-Assam Bora Rice Starch Based Multi Particulate System Containing Naproxen. Starch-Starke 2020.
  • Semde, R.; Amighi, K.; Devleeschouwe, M. J.; Moes, A. J. Effect of Pectinolytic Enzymes on the Theophylline Release from Pellets Coated with Water Insoluble Polymers Containing Pectin HM or Calcium Pectinate. Int. J. Pharm. 2000, 197, 181–192.
  • MacLeod, G. S.; Fell, J. T.; Collett, J. H.; Sharma, H. L.; Smith, A. M. Selective Drug Delivery to the Colon Using Pectin: Chitosan: Hydroxypropyl Methylcellulose Film Coated Tablets. Int. J. Pharm. 1999, 187, 251–257. doi:10.1016/S0378-5173(99)00196-9.
  • Tiwari, A.; Verma, A.; Panda, P. K.; Saraf, S.; Jain, A.; Jain, S. K. Stimuli-Responsive Polysaccharides for Colon-Targeted Drug Delivery. In Stimuli Responsive Polymeric Nanocarriers for Drug Delivery Applications: Advanced Nanocarriers for Therapeutics, Chapter No 20; Makhlouf, A. S. H., Abu-Thabit, N. Y., Eds.; Woodhead Publishing: Cambridge, MA, 2018; Vol. 2, pp 547–562.
  • Salyers, A. A.; Vercellotti, J. R.; West, S. E. H.; Wilkins, T. D. Fermentation of Mucin and Plant Polysaccharides by Strains of Bacteroides from the Human Colon. Appl. Environ. Microbiol. 1977, 33, 319–322. doi:10.1128/AEM.33.2.319-322.1977.
  • Ashford, M.; Fell, J. T.; Attwood, D.; Sharma, H. L.; Woodhead, P. J. Studies on Pectin Formulations for Colonic Drug Delivery. J. Control. Release 1994, 30, 225–232. doi:10.1016/0168-3659(94)90028-0.
  • Ofori, K. K.; Fell, J. T. Biphasic Drug Release from Film Coated Tablets. Int. J. Pharm. 2003, 250, 431–440. doi:10.1016/S0378-5173(02)00578-1.
  • Sriamornsak, P.; Prakongpan, S.; Puttipipatkhachorn, S.; Kennedy, R. A. Development of Sustained Release Theophylline Pallets Coated with Calcium Pectinate. J. Control. Release 1997, 47, 221–232. doi:10.1016/S0168-3659(97)01640-4.
  • Dupuis, G.; Chambin, O.; Genelot, C.; Champion, D.; Pourcelot, Y. Colonic Drug Delivery: Influence of Cross Linking Agent on Pectin Beads Properties and Role of Capsule Shell Type. Drug Dev. Ind. Pharm. 2006, 32, 847–855. doi:10.1080/03639040500536718.
  • Wei, H.; Qing, D.; De, Y. C.; Bai, X.; Li, F. F. In-Vitro and in-Vivo Studies of Pectin/Ethylcellulosefilm-Coated Pellets of 5-Fluorouracil for Colonic Targeting. J. Pharm. Pharmacol. 2008, 60, 35–44. doi:10.1211/jpp.60.1.0005.
  • Kumar, R. S.; Kumar, M.; Ganesh, G. N.; Jawahar, N.; Nagasamy, V. D.; Senthil, V. Formulation and Evaluation of Pectin-Hydroxypropyl Methylcellulose Coated Curcumin Pellets for Colon Delivery. Asia. J. Pharm. 2009, 3, 138–142. doi:10.4103/0973-8398.55052.
  • Lee, C. M.; Kim, D. W.; Lee, H. C.; Lee, K. Y. Pectin Microspheres for Oral Colon Delivery: Preparation Using Spray Drying Method and In Vitro Release of Indomethacin. Biotechnol. Bioprocess Eng. 2004, 9, 191–195. doi:10.1007/BF02942291.
  • Momin, M.; Pundarikakshudu, K.; Nagori, S. A. Design and Development of Mixed Film of Pectin: Ethyl Cellulose for Colon Specific Drug Delivery of Sennosides and Triphala. Indian J. Pharm. Sci. 2008, 70, 338–343. doi:10.4103/0250-474X.42998.
  • Cheewatanakornkool, K.; Niratisai, S.; Manchun, S.; Dass, C. R.; Sriamornsak, P. Characterization and In Vitro Release Studies of Oral Microbeads Containing Thiolated Pectin-Doxorubicin Conjugates for Colorectal Cancer Treatment. Asian J. Pharm. Sci. 2017, 12, 509–520. doi:10.1016/j.ajps.2017.07.005.
  • Li, C.; Li, J. B.; Lei, C. Y.; Liu, P. H. Preparation and In Vitro Release Mechanisms of Modified Pectin Matrix Tablets for Colon-Targeted Drug Delivery. Bio. Res. 2017, 12, 1491–1505.
  • Leclere, L.; Van Cutsem, P.; Michiels, C. Anti-Cancer Activities of pH- or Heat-Modified Pectin. Front. Pharmacol. 2013, 4, 128doi:10.3389/fphar.2013.00128.
  • Majumdar, S.; Roy, S.; Ghosh, B. Design and Gamma Scintigraphic Evaluation of Colon Specific Pectin-EC Pellets of Secnidazole Prepared by Powder Layering Technology. Pharmazie 2011, 66, 843–848.
  • Jana, S.; Gandhi, A.; Sen, K. K.; Basu, S. K. Natural Polymers and Their Application in Drug Delivery and Biomedical Field. J. Pharm. Sci. Tech. 2011, 1, 16–27.
  • Svagan, A. J.; Kusic, A.; De Gobba, C.; Larsen, F. H.; Sassene, P.; Zhou, Q.; van de Weert, M.; Mullertz, A.; Jørgensen, B.; Ulvskov, P. Rhamnogalacturonan-I Based Microcapsules for Targeted Drug Release. PLoS One. 2016, 11, e0168050. doi:10.1371/journal.pone.0168050.
  • Tan, H.; Chen, W.; Liu, Q.; Yang, G.; Li, K. Pectin Oligosaccharides Ameliorate Colon Cancer by Regulating Oxidative Stress and Inflammation-Activated Signalling Pathways. Front. Immunol. 2018, 9, 1–13. doi:10.3389/fimmu.2018.01504.
  • Ofosua, A. D.; Kwabena, O. K.; Mariam, E. B. G.; Samuel, O. B.; Samuel, O. In Vitro Evaluation of Cocoa Pod Husk Pectin as a Carrier for Chronodelivery of Hydrocortisone Intended for Adrenal Insufficiency. J. Drug. Deliv. 2017, 2017, 1–10.
  • Abdalrahim, F. A. A.; Abdulmajid, A. M. S.; Ismail, Z.; Salman, A. A.; Abu-Salah, K. M. Development of Polymeric Nanoparticles of Garcinia Mangostana Xanthones in Eudragit RL100/RS100 for anti-Colon Cancer Drug Delivery. J. Nanomat. 2015, 2015, 1–12. doi:10.1155/2015/701979.
  • Srivastava, P.; Malviya, R. Sources of Pectin, Extraction and Its Applications in Pharmaceutical industries-An Overview. Ind. J. Nat. Prod. Res. 2011, 2, 10–18.
  • Torkova, A. A.; Lisitskaya, K. V.; Filimonov, I. S.; Glazunova, O. A.; Kachalova, G. S.; Golubev, V. N.; Fedorova, T. V. Physicochemical and Functional Properties of Cucurbita Maxima Pumpkin Pectin and Commercial Citrus and Apple Pectins: A Comparative Evaluation. PLoS One 2018, 13, e0204261. doi:10.1371/journal.pone.0204261.
  • Guochuan, S.; Zongping, Z.; Lee, M. H.; Xu, Y.; Kang, S.; Dong, Z.; Wang, M.; Gu, Z.; Li, H.; Chen, W. Chemoprevention of Colorectal Cancer by Artocarpin, a Dietary Phytochemical from Artocarpus heterophyllus. J. Agric. Food Chem. 2017, 65, 3474–3480. doi:10.1021/acs.jafc.7b00278.
  • Zou, M.; Wang, C.; Zhang, X.; Xu, T.; Han, J.; Zhang, X.; Cheng, G. A Suppository-Base-Matrix Tablet for Time-Dependent Colonspecific Delivery System. Braz. J. Pharm. Sci. 2014, 50, 535–541. doi:10.1590/S1984-82502014000300012.
  • Maxwell, E. G.; Colquhoun, I. J.; Chau, H. K.; Hotchkiss, A. T.; Waldron, K. W.; Morris, V. J.; Belshaw, N. J. Rhamnogalacturonan I Containing Homogalacturonan Inhibits Colon Cancer Cell Proliferation by Decreasing ICAM1 Expression. Carbohydr. Polym. 2015, 132, 546–553. doi:10.1016/j.carbpol.2015.06.082.
  • Delphi, L.; Sepehri, H.; Khorramizadeh, M. R.; Mansoori, F. Pectic-Oligoshaccharides from Apples Induce Apoptosis and Cell Cycle Arrest in MDA-MB-231 Cells, a Model of Human Breast Cancer. Asian. Pac. J. Cancer. Prev. 2015, 16, 5265–5271. doi:10.7314/APJCP.2015.16.13.5265.
  • Jaganathan, S. K.; Vellayappan, M. V.; Narasimhan, G.; Supriyanto, E.; Octorina Dewi, D. E.; Narayanan, A. L. T.; Balaji, A.; Subramanian, A. P.; Yusof, M. Chemopreventive Effect of Apple and Berry Fruits against Colon Cancer. World J. Gastroenterol. 2014, 20, 17029–17036. doi:10.3748/wjg.v20.i45.17029.
  • Waldecker, M.; Kautenburger, T.; Daumann, H.; Veeriah, S.; Will, F.; Dietrich, H.; Pool-Zobel, B. L.; Schrenk, D. Histone-Deacetylase Inhibition and Butyrate Formation: Fecal Slurry Incubations with Apple Pectin and Apple Juice Extracts. Nutrition 2008, 24, 366–374. doi:10.1016/j.nut.2007.12.013.
  • Direito, R.; Lima, A.; Rocha, J.; Ferreira, R. B.; Mota, J.; Rebelo, P.; Fernandes, A.; Pinto, R.; Alves, P.; Bronze, R.; et al. Dyospiros Kaki Phenolics Inhibit Colitis and Colon Cancer Cell Proliferation, but Not Gelatinase Activities. J. Nutr. Biochem. 2017, 46, 100–108. doi:10.1016/j.jnutbio.2017.03.002.
  • Yaqub, S.; Farooq, U.; Shafi, A.; Akram, K.; Murtaza, M. A.; Kausar, T.; Siddique, F. Chemistry and Functionality of Bioactive Compounds Present in Persimmon. J. Chem. 2016, 2016, 1–13. doi:10.1155/2016/3424025.
  • Salima, T. M.; Vladimir, F. M.; Daria, M. A.; Anna, V. K.; Lubov, G. M.; Yulia, M. Z.; Vasili, A. M. Biological Activity and Pharmacological Application of Pectic Polysaccharides: A Review. Polymers 2018, 10, 1–31.
  • Günter, E. A.; Popeyko, O. V. Calcium Pectinate Gel Beads Obtained from Callus Cultures Pectins as Promising Systems for Colon-Targeted Drug Delivery. Carbohydr. Polym. 2016, 147, 490–499. doi:10.1016/j.carbpol.2016.04.026.
  • Subudhi, M. B.; Jain, A.; Jain, A.; Hurkat, P.; Shilpi, S.; Gulbake, A.; Jain, S. K. Eudragit S100 Coated Citrus Pectin Nanoparticles for Colon Targeting of 5-Fluorouracil. Materials (Basel) 2015, 8, 832–849. doi:10.3390/ma8030832.
  • Liu, H. Y.; Huang, Z. L.; Yang, G. H.; Lu, W. Q.; Yu, N. R. Inhibitory Effect of Modified Citrus Pectin on Liver Metastases in a Mouse Colon Cancer Model. WJG 2008, 14, 7386–7391. doi:10.3748/wjg.14.7386.
  • Bergman, M.; Djaldetti, M.; Salman, H.; Bessler, H. Effect of Citrus Pectin on Malignant Cell Proliferation. Biomed. Pharmacother. 2010, 64, 44–47. doi:10.1016/j.biopha.2009.03.004.
  • Prado, S. B. R.; Ferreira, G. F.; Harazono, Y.; Shiga, T. M.; Raz, A.; Nicholas, C. C.; Fabi, J. P. Ripening-Induced Chemical Modifications of Papaya Pectin Inhibit Cancer Cell Proliferation. Sci. Rep. 2017, 7, 1–17.
  • Maxwell, E. G.; Colquhoun, I. J.; Chau, H. K.; Hotchkiss, A. T.; Waldron, K. W.; Morris, V. J.; Belshaw, N. J. Modified Sugar Beet Pectin Induces Apoptosis of Colon Cancer Cells via an Interaction with the Neutral Sugar Side-Chains. Carbohydr. Polym. 2016, 136, 923–929. doi:10.1016/j.carbpol.2015.09.063.
  • Tozaki, H.; Komoike, J.; Tada, C.; Maruyama, T.; Terabe, A.; Suzuki, T.; Yamamoto, A.; Muranishi, S. Chitosan Capsules for Colon Specific Drug Delivery: Improvement of Insulin Absorption from Rat Colon. J. Pharm. Sci. 1997, 86, 1016–1021. doi:10.1021/js970018g.
  • Tozaki, H.; Fujita, T.; Odoriba, T.; Terabe, A.; Suzuki, T.; Tanaka, C.; Okabe, S.; Muranishi, S.; Yamamoto, A. Colon Specific Delivery of R68070, a New Thromboxane Synthetase Inhibitor, Using Chitosan Capsules: Therapeutic Effects against 2,4,6-Trinitrobenzene Sulfonic Acid-Induced Ulcerative Colitis in Rats. Life Sci. 1999, 64, 1155–1162. doi:10.1016/S0024-3205(99)00044-2.
  • Tominaga, S.; Takaizawa, T.; Yamada, M. 1998. Colon Drug Delivery System. JP 10 324, 642 (98324, 642) (Cl A61 K47/36); 8 Dec., 1998, JP Appl. 97/73, 599, 26 Mar., 1997, 9PT (Japan).
  • Tozaki, H.; Odoriba, T.; Okada, N.; Fujita, T.; Terabe, A.; Suzuki, T.; Okabe, S.; Muranishi, S.; Yamamoto, A. Chitosan Capsules for Colon Specific Drug Delivery: Enhanced Localization of 5-Aminosalicylic Acid in the Large Intestine Accelerates Healing of TNBS-Induced Colitis in Rats. J. Control. Release 2002, 82, 51–61. doi:10.1016/S0168-3659(02)00084-6.
  • Zhang, H.; Alsarra, I. A.; Neau, S. H. An In Vitro Evaluation of a Chitosan-Containing Multiparticulate System for Macromolecule Delivery to the Colon. Int. J. Pharm. 2002, 239, 197–205. doi:10.1016/S0378-5173(02)00112-6.
  • Orienti, I.; Cerchiara, T.; Luppi, B.; Bigucci, F.; Zuccari, G.; Zecchi, V. Influence of Different Chitosan Salts on the Release of Sodium Diclofenac in Colon-Specific Delivery. Int. J. Pharm. 2002, 238, 51–59. doi:10.1016/S0378-5173(02)00060-1.
  • Chang, K. L. B.; Lin, J. Swelling Behavior and the Release of Protein from Chitosan-Pectin Composite Particles. Carbo. Polym. 2000, 43, 163–169. doi:10.1016/S0144-8617(00)00145-4.
  • Raghavan, C. V.; Muthulingam, C.; Jenita, J.; Ravi, T. K. An In Vitro and In Vivo Investigation into the Suitability of Bacterially Triggered Delivery System for Colon Targeting. Chem. Pharm. Bull. 2002, 50, 892–895. doi:10.1248/cpb.50.892.
  • Lorenzo-Lamosa, M. L.; Lopez, C. R.; Vila-Jato, J. L.; Alonso, M. J. Design of Microencapsulated Chitosan Microspheres for Colonic Drug Delivery. J. Control. Release 1998, 52, 109–118. doi:10.1016/S0168-3659(97)00203-4.
  • Shu, X. Z.; Zhu, K. J.; Song, W. Novel pH-Sensitive Citrate Cross-Linked Chitosan Film for Drug Controlled Release. Int. J. Pharm. 2001, 212, 19–28. doi:10.1016/S0378-5173(00)00582-2.
  • Shimono, N.; Takatori, T.; Ueda, M.; Mori, M.; Higashi, Y.; Nakamura, Y. Chitosan Dispersed System for Colon-Specific Drug Delivery. Int. J. Pharm. 2002, 245, 45–54. doi:10.1016/S0378-5173(02)00344-7.
  • Iglesias, N.; Galbis, E.; Díaz-Blanco, M. J.; Lucas, R.; Benito, E.; De-Paz, M. V. Nanostructured Chitosan-Based Biomaterials for Sustained and Colon-Specific Resveratrol Release. IJMS 2019, 20, 398. doi:10.3390/ijms20020398.
  • Li, J.; Cai, C.; Li, J.; Li, J.; Li, J.; Sun, T.; Wang, L.; Wu, H.; Yu, G. Chitosan-Based Nanomaterials for Drug Delivery. Molecule 2018, 23, 2661. doi:10.3390/molecules23102661.
  • Galbiati, A.; Tabolacci, C.; Rocca, B. M. D.; Mattioli, P.; Beninati, S.; Paradossi, G.; Desideri, A. Targeting Tumor Cells through Chitosan-Folate Modified Microcapsules Loaded with Camptothecin. Bioconjug. Chem. 2011, 22, 1066–1072. doi:10.1021/bc100546s.
  • Yoshida, T.; Lai, T. C.; Kwon, G. S.; Sako, K. pH- and Ion-Sensitive Polymers for Drug Delivery. Exp. Opin. Drug Deliv. 2013, 10, 1497–1513. doi:10.1517/17425247.2013.821978.
  • Zhao, W.; Odelius, K.; Edlund, U.; Zhao, C.; Albertsson, A. C. In Situ Synthesis of Magnetic Field-Responsive Hemicellulose Hydrogels for Drug Delivery. Biomacromolecules 2015, 16, 2522–2528. doi:10.1021/acs.biomac.5b00801.
  • Kadria, A.; Elkhodairy, H.; Elsaghir, A.; Al-Subayiel, A. M. Formulation of Indomethacin Colon Targeted Delivery Systems Using Polysaccharides as Carriers by Applying Liquisolid Technique. Biomed. Res. Int. 2014, 2014, 704362–704318. doi:10.1155/2014/704362.
  • Seeli, D. S.; Dhivya, S.; Selvamurugan, N.; Prabaharan, M. Guar Gum Succinate-Sodium Alginate Beads as a pH-Sensitive Carrier for Colon-Specific Drug Delivery. Int. J. Biol. Macromol. 2016, 91, 45–50. doi:10.1016/j.ijbiomac.2016.05.057.
  • Pinhassi, R. I.; Assaraf, Y. G.; Farber, S.; Stark, M.; Ickowicz, D.; Drori, S.; Domb, A. J.; Livney, Y. D. Arabinogalactan-Folic Acid-Drug Conjugate for Targeted Delivery and Target-Activated Release of Anticancer Drugs to Folate Receptor-Overexpressing Cells. Biomacromolecules 2010, 11, 294–303. doi:10.1021/bm900853z.
  • Takei, T.; Sato, M.; Ijima, H.; Kawakami, K. In Situ Gellable Oxidized Citrus Pectin for Localized Delivery of Anticancer Drugs and Prevention of Homotypic Cancer Cell Aggregation. Biomacromolecules 2010, 11, 3525–3530. doi:10.1021/bm1010068.
  • Shukla, S.; Jain, D.; Verma, K.; Verma, S. Pectin-Based Colon Specific Drug Delivery. Chron. Young Sci. 2011, 2, 83–89. doi:10.4103/2229-5186.82978.
  • Wu, L.; Wang, H.; Xiaohua, Z.; Yinchen, H.; Wangwang, L.; Gongming, Y.; Jiang, A. Pectin-Chitosan Complex: Preparation and Application in Colon-Specific Capsule. Int. J. Agric. Biol. Eng. 2015, 8, 151–160.
  • Varshosaz, J.; Emami, J.; Ahmadi, F.; Tavakoli, N.; Minaiyan, M.; Fassihi, A.; Mahzouni, P.; Dorkoosh, F. Preparation of Budesonide-Dextran Conjugates Using Glutarate Spacer as a Colon-Targeted Drug Delivery System: In Vitro/In Vivo Evaluation in Induced Ulcerative Colitis. J. Drug. Target 2011, 19, 140–153. doi:10.3109/10611861003801826.
  • Siew, L. F.; Basit, A. W.; Newton, J. M. The Potential of Organic-Based Amylose-Ethylcellulose Film Coatings as Oral Colon-Specific Drug Delivery Systems. AAPS Pharm. Sci. Tech. 2000, 1, 53–61. doi:10.1208/pt010322.
  • Karrout, Y.; Neut, C.; Wils, D.; Siepmann, F.; Deremaux, L.; Desreumaux, P.; Siepmann, J. Characterization of Ethylcellulose: Starch-Based Film Coatings for Colon Targeting. Drug Develop. Indus. Pharm. 2009, 35, 1190–1200. doi:10.1080/03639040902858868.
  • Emeje, M.; Nwabunike, P.; Isimi, Y.; Kunle, O.; Ofoefule, S. Preparation and Evaluation of Colon Targeted Drug Delivery Systems for Albendazole Using Kneading, Extrusion and Compaction Technology. Yao Xue Xue Bao 2009, 44, 1152–1158.
  • Ramteke, K. H.; Nath, L. Formulation, Evaluation and Optimization of Pectin-Bora Rice Beads for Colon Targeted Drug Delivery System. Adv. Pharm. Bull. 2014, 4, 167–177. doi:10.5681/apb.2014.025.
  • Hsu, F. Y.; Yu, D. S.; Huang, C. C. Development of pH-Sensitive Pectinate/Alginate Microspheres for Colon Drug Delivery. J. Mater. Sci. Mater. Med. 2013, 24, 317–323. doi:10.1007/s10856-012-4798-9.
  • Wang, Q. S.; Wang, G. F.; Zhou, J.; Gao, L. N.; Cui, Y. L. Colon Targeted Oral Drug Delivery System Based on Alginate-Chitosan Microspheres Loaded with Icariin in the Treatment of Ulcerative Colitis. Int. J. Pharm. 2016, 515, 176–185. doi:10.1016/j.ijpharm.2016.10.002.
  • Krishnaiah, Y. S. R.; Satyanarayana, S.; Prasad, Y. V. R.; Rao, S. N. Evaluation of Guar Gum as a Compression Coat for Drug Targeting to Colon. Int. J. Pharm. 1998, 171, 137–146. doi:10.1016/S0378-5173(98)00172-0.
  • Krishnaiah, Y. S. R.; Karthikeyan, R. S.; Sankar, V. G.; Satyanarayana, V. Three-Layer Guar Gum Matrix Tablet Formulations for Oral Controlled Delivery of Highly Soluble Trimetazidine Dihydrochloride. J. Control. Release 2002, 81, 45–56. doi:10.1016/S0168-3659(02)00031-7.
  • Krishnaiah, Y. S. R.; Raju, P. V.; Kumar, B. D.; Bhaskar, P.; Satyanarayana, V. Development of Colon Targeted Drug Delivery Systems for Mebendazole. J. Control. Release 2001, 77, 87–95. doi:10.1016/S0168-3659(01)00461-8.
  • Gliko, K. I.; Yagen, B.; Baluom, M.; Rubinstein, A. Phosphated Crosslinked Guar for Colon-Specific Drug Delivery II. In Vitro and In Vivo Evaluation in the Rat. J. Control. Release 2000, 63, 129–134. doi:10.1016/S0168-3659(99)00180-7.
  • Wong, D.; Larrabee, S.; Clifford, K.; Tremblay, J.; Friend, D. R. USP Dissolution Apparatus III (Reciprocating Cylinder) for Screening of Guar-Based Colonic Delivery Formulations. J. Control. Release 1997, 47, 173–179. doi:10.1016/S0168-3659(97)01633-7.
  • Cole, E. T.; Scott, R. A. Drug Delivery Composition for Release of Drug in Small Intestine, Colon or Terminal Ileum Comprises Hydroxypropylmethyl Cellulose Capsule Containing the Drug and Provided with a Coating Preventing Release of Drug in Stomach. W.O. 200018377-A1, Apr 06, 2000.
  • Friend, D. R. Wong, D. Oral Delivery of Drugs to Lower Gastrointestinal Tract Particularly Colon, Without Significant Release of Drug in Upper Gastrointestinal Tract, for Treating Chronic Bowel Diseases e.g. Crohn’s disease. W.O. 9640078-A1, Dec 19, 1996.
  • Krishnaiah, Y. S.; Satyanarayana, S.; Prasad, Y. V.; Rao, S. N. Gamma Scientigraphic Studies on Guar-Gum Matrix Tablet for Colonic Drug Delivery in Healthy Human Volunteers. J. Control. Release 1998, 55, 245–252. doi:10.1016/S0168-3659(98)00057-1.
  • Krishnaiah, Y. S. R.; Veer Raju, P.; Dinesh Kumar, B.; Satyanarayana, V.; Karthikeyan, R. S.; Bhaskar, P. Pharmacokinetic Evaluation of Guar Gum-Based Colon-Targeted Drug Delivery Systems of Mebendazole in Healthy Volunteers. J. Control. Release 2003, 88, 95–103. doi:10.1016/S0168-3659(02)00483-2.
  • Ji, C. M.; Xu, H. N.; Wu, W. Guar Gum as Potential Film Coating Material for Colon-Specific Delivery of Fluorouracil. J. Biomater. Appl. 2009, 23, 311–329. doi:10.1177/0885328208089617.
  • Hehre, E. J.; Sery, T. W. Dextran Splitting Anaerobic Bacteria from the Human Intestine. J. Bacteriol. 1952, 63, 424–426. doi:10.1128/JB.63.3.424-426.1952.
  • Hennink, W. E. Stenekes, R. J. H. Production of Hydrogel of Dextran or Its Derivative Useful in the Preparation of a Controlled Released agent Involves Crystallization of an Aqueous Solution of the Dextran or Its Derivative Having a Specified Molecular Weight. E.P. 1184032-A1, Mar 06, 2002.
  • Usher, T. C.; Patel, N.; Tanenbaum, S. W. Complexes of Podophyllotoxin and Dextran, Dextran Sulphate or Polysaccharide Can Be Used to Treat Cancer, Esp. of the Colon and Are Less Toxic, More Water Soluble and More Effective than Podophyllotoxin Used Alone. C.A. 2091410-A, Sep 11, 1994.
  • McLeod, A. D.; Friend, D. R.; Tozer, T. N. Glucocorticoid-Dextran Conjugates as Potential Prodrugs for Colon-Specific Delivery: Hydrolysis in Rat Gastrointestinal Tract Contents. J. Pharm. Sci. 1994, 83, 1284–1288. doi:10.1002/jps.2600830919.
  • Takeuchi, H.; Yasuji, T.; Yamamoto, H.; Kawashima, Y. Spray-Dried Lactose Composite Particles Containing an Ion Complex of Alginate-Chitosan for Designing a Dry-Coated Tablet Having a Time-Controlled Releasing Function. Pharm. Res. 2000, 17, 94–99. doi:10.1023/a:1007530927887.
  • Agarwal, T.; Narayana, S. N. G. H.; Pal, K.; Pramanik, K.; Giri, S.; Banerjee, I. Calcium Alginate-Carboxymethyl Cellulose Beads for Colon-Targeted Drug Delivery. Int. J. Biol. Macromol. 2015, 75, 409–417. doi:10.1016/j.ijbiomac.2014.12.052.
  • Sinha, V. R.; Kumria, R. Polysaccharides in Colon Specific Drug Delivery. Int. J. Pharm. 2001, 224, 19–38. doi:10.1016/S0378-5173(01)00720-7.
  • Hirayama, F.; Ogata, T.; Yano, H.; Arima, H.; Udo, K.; Takano, M.; Uekama, K. Release Characteristics of a Short-Chain Fatty Acid, Nbutyric Acid, from Its Beta-Cyclodextrin Ester Conjugate in Rat Biological Media. J. Pharm. Sci. 2000, 89, 1486–1495. doi:10.1002/1520-6017(200011)89:11<1486::AID-JPS11>3.3.CO;2-4.
  • Yano, H.; Hirayama, F.; Kamada, M.; Arima, H.; Uekama, K. Colon-Specific Delivery of Prednisolone-Appended Alpha-Cyclodextrin Conjugate: Alleviation of Systemic Side Effect after Oral Administration. J. Control. Release 2002, 79, 103–112. doi:10.1016/S0168-3659(01)00532-6.
  • Siefke, V.; Hanstein, U.; Weckenmann, H. P.; Bauer, K. H.; Bauer, K.; Weckenmann, H.; Heumann, U. Oral Pharmaceutical Forms for Release in the Colon Are Coated with Mixt. Containing Film Former Insoluble in Water and Stomach Juices and Cyclodextrin or Deriv. D.E. 4236025-A1, Apr 28, 1994.
  • Wilson, C. G.; Mukherji, G.; Sha, H. K. Modified-Release Drug Delivery Technology. In Biopolymers and Colonic Delivery, 2nd ed.; Rathbone, M. J., Had, G. J., Roberts, M. S., Lane, M. E. Informa Healthcare: New York, 2008; Vol. 1, pp 295–309.
  • Rajpurohit, H.; Sharma, P.; Sharma, S.; Bhandari, A. Polymers for Colon Targeted Drug Delivery. Indian J. Pharm. Sci. 2010, 72, 689–696. doi:10.4103/0250-474X.84576.
  • Jain, A.; Gupta, Y.; Jain, S. K. Perspectives of Biodegradable Natural Polysaccharides for Site-Specific Drug Delivery to the Colon. J. Pharm. Pharm. Sci. 2007, 10, 86–128.
  • Minami, K.; Hirayama, F.; Uekama, K. Colon-Specific Drug Delivery Based on a Cyclodextrin Prodrug: Release Behavior of Biphenylylacetic Acid from Its Cyclodextrin Conjugates in Rat Intestinal Tracts after Oral Administration. J. Pharm. Sci. 1998, 87, 715–720. doi:10.1021/js9704339.
  • Gibson, G. R.; Roberfroid, M. B. Dietary Modulation of the Human Colonic Microbiota: Introducing the Concept of Prebiotics. J. Nutr. 1995, 125, 1401–1414. doi:10.1093/jn/125.6.1401.
  • Maris, B.; Verheyden, L.; Van, R. K.; Samyn, C.; Augustijns, P.; Kinget, R.; Van-den, M. G. Synthesis and Characterisation of Inulinazo Hydrogels Designed for Colon Targeting. Int. J. Pharm. 2001, 213, 143–152. doi:10.1016/S0378-5173(00)00654-2.
  • Vervoort, L.; Mooter, G. V.; Augustijns, P.; Kinget, R. Inulin Hydrogels. I. Dynamic and Equilibrium Swelling Properties. Int. J. Pharm. 1998, 172, 127–135. doi:10.1016/S0378-5173(98)00200-2.
  • Vervoort, L.; Rombaut, P.; Mooter, G. V.; Augustijns, P.; Kinget, R. Inulin Hydrogels. II. In Vitro Degradation Study. Int. J. Pharm. 1998, 172, 137–145. doi:10.1016/S0378-5173(98)00201-4.
  • Vilivalam, V. D.; Illum, I.; Iqbal, I. Starch Capsules: An Alternative System for Oral Drug Delivery. Pharm. Sci. Technol. Today. 2000, 3, 64–69. doi:10.1016/S1461-5347(99)00238-2.
  • Conway, P. L.; Henriksson, K. A.; Mcnaught, K. J.; Wang, X.; Henriksson, K. A. O.; Brown, I. L. Enhancing a Population of Target Microorganisms in Gastrointestinal Tract of Animal by Providing the Animal with Modified or Unmodified Resistant Starch, e.g. Hydroxypropylated Starch. W.O. 9734592-A1, Sep 25, 1997.
  • Brown, I. L.; Conway, P. L.; Evans, A. J.; Henriksson, K. A.; Mcnaught, K. J.; Wang, X.; Henriksson, K. A. O. Altering Gastrointestinal Tract Microbial Populations by Administration of Probiotic Bacteria with Optionally Modified Resistant Starch as Carrier and Growth Medium, Useful for Preventing Colorectal Cancer. W.O. 9734591-A1, Sep 25, A61k-031/175, 1997.
  • Englyst, H. N.; MacFarlane, G. T. Breakdown of Resistant and Readily Digestible Starch of Human Gut Bacteria. J. Sci. Food Agric. 1986, 37, 699–706. doi:10.1002/jsfa.2740370717.
  • Cummings, J. H.; Milojevic, S.; Harding, M.; Coward, W. A.; Gibson, G. R.; Louise Botham, R.; Ring, S. G.; Wraight, E. P.; Stockham, M. A.; Allwood, M. C.; Newton, J. M. In-Vivo Studies of Amylose and Ethyl Cellulose Coated Glucose Microspheres as a Model for Drug Delivery to the Colon. J. Control. Release 1996, 40, 123–131. doi:10.1016/0168-3659(95)00186-7.
  • Allwood, M. C.; Ring, S. G.; Archer, D. B.; Davies, J. D.; Touitou, E.; Rubinstein, A. Delayed Release Composition Comprising Glassy Amylose to Delay Active Agent Release in Acidic-to-Weakly Basic Aqueous Media but Permitting Release after Enzymatic Hydrolysis, e.g. in the Colon: Capsule for Targeted Delivery of Drugs to the Colon Containing Absorption Promoter and Coated with Polymer Insoluble at pH Below 7, E.P. 343993-a, Nov 29, A61k-009/22, 1989.
  • Milojevic, S.; Newton, J. M.; Cummings, J. H.; Gibson, G. R.; Louise Botham, R.; Ring, S. G.; Stockham, M.; Allwood, M. C. Amylose as a Coating for Drug Delivery to the Colon: Preparation and In Vitro Evaluation Using Glucose Pellets. J. Control. Release 1996, 38, 85–94. doi:10.1016/0168-3659(95)00113-1.
  • Lenaerts, V.; Dumoulin, Y.; Mateescu, M. A. Controlled Release of Theophylline from Cross-Linked Amylose Tablets. J. Control. Release 1991, 15, 39–46. doi:10.1016/0168-3659(91)90101-I.
  • Milojevic, S.; Newton, J. M.; Cummings, J. H.; Gibson, G. R.; Louise Botham, R.; Ring, S. G.; Stockham, M.; Allwood, M. C. Amylose as a Coating for Drug Delivery to the Colon: Preparation and In Vitro Evaluation Using 5-Aminosalicylic Acid Pellets. J. Control. Release 1996, 38, 75–84. doi:10.1016/0168-3659(95)00112-3.
  • Salyers, A. A.; Brien, M. Cellular Location of Enzymes Involved in Chondroitin Sulfate Breakdown by Bacteroides Thetaiotaomicron. J. Bacteriol. 1980, 143, 772–780. doi:10.1128/JB.143.2.772-780.1980.
  • Rubinstein, A.; Nakar, D.; Sintov, A. Chondroitin Sulphate: A Potential Biodegradable Carrier for Colon-Specific Drug Delivery. Int. J. Pharm. 1992, 84, 141–150. doi:10.1016/0378-5173(92)90054-6.
  • Rubinstein, A.; Nakar, D.; Sintov, A. Colonic Drug Delivery: Enhanced Release of Indomethacin from Crosslinked Chondroitin Matrix in Rat Caecal Content. Pharm. Res. 1992b, 09, 276–278. doi:10.1023/A:1018910128452.
  • Amrutkar, J. R.; Gattani, S. G. Chitosan-Chondroitin Sulfate Based Matrix Tablets for Colon Specific Delivery of Indomethacin. AAPS PharmSciTech 2009, 10, 670–677. doi:10.1208/s12249-009-9253-y.
  • Cavalcanti, O. A.; Silva, C. C.; Pineda, E. G.; Hechenleitner, A. W. Synthesis and Characterization of Phosphated Crosslinked Chondroitin Sulfate: Potencial Ingredient for Specific Drug Delivery. Acta. Farma. Bona 2005, 24, 234–238.
  • Amnuaikit, C.; Ikeuchi, I.; Ogawara, K.; Higaki, K.; Kimura, T. Skin Permeation of Propranolol from Polymeric Film Containing Terpene Enhancers for Transdermal Use. Int. J. Pharm. 2005, 289, 167–178. doi:10.1016/j.ijpharm.2004.11.007.
  • Bashardoust, N.; Jenita, J. J. L.; Milani, P. Z. Physicochemical Characterization and Dissolution Study of Ibuprofen Compression-Coated Tablets Using Locust Bean Gum. Dissolution Technol. 2013, 20, 38–43. doi:10.14227/DT200113P38.
  • Hirose, K.; Endo, K.; Hasegawa, K. A Convenient Synthesis of Lepidimoide from Okra Mucilage and Its Growth-Promoting Activity in Hypocotyls. Carbohydr. Res. 2004, 339, 9–19. doi:10.1016/j.carres.2003.10.003.
  • Ilango, K. B.; Manisha, M.; Sridurga, D.; Rajsekaran, A.; Kumar, M. S.; Subburaju, T. In Vitro and In Vivo Evaluation of Okra Polysaccharide-Based Colon-Targeted Drug Delivery Systems. Int. J. Pharm. Sci. Rev. Res. 2010, 5, 138–145.
  • Rajkumari, A.; Kataki, M. S.; Ilango, K. B.; Rajak, P. Studies on the Development of Colon Specific Drug Delivery System of Ibuprofen Using Polysaccharide Extracted from Abelmoschus esculentus L. Asian J. Pharm. Sci. 2012, 7, 67–74.
  • Rajendra, A.; Bushetti, S. S.; Giri, A. Design and Evaluation of Compression Coated Formulations for an Antiinflammatory Drug Based on Modified Okra Mucilage. J. Appl. Pharm. Sci. 2012, 2, 238–245.
  • Ashton, W. A.; Jefferies, M.; Morley, R. G.; Pass, G.; Phillips, G. O.; Power, D. M. J. Physical Properties and Applications of Aqueous Solutions of Albizia zygia Gum. J. Sci. Food Agric. 1975, 26, 697–704. doi:10.1002/jsfa.2740260516.
  • US National Academy of Sciences. Tropical Legumes, National Academy of Sciences; US National Academy of Sciences: Washington, DC, 1979.
  • Odeku, O. A.; Fell, J. T. In-Vitro Evaluation of Khaya and Albizia Gums as Compression Coatings for Drug Targeting to the Colon. J. Pharm. Pharmacol. 2005, 57, 163–168. doi:10.1211/0022357055362.
  • Bharaniraja, B.; Kumar, K. J.; Prasad, C. M.; Sen, A. K. Modified Katira Gum for Colon Targeted Drug Delivery. J. Appl. Polym. Sci. 2011, 119, 2644–2651. doi:10.1002/app.32829.
  • Odeku, O. A.; Okunlola, A.; Lamprecht, A. Formulation and In Vitro Evaluation of Natural Gum-Based Microbeads for Delivery of Ibuprofen. Trop. J. Pharm. Res. 2014, 13, 1577–1583. doi:10.4314/tjpr.v13i10.2.
  • Nayak, A. K.; Pal, D. K. Tamarind  , Seed Polysaccharide: An Emerging Excipient for Pharmaceutical Use. Ind. J. Pharm. Edu. Res. 2017, 51, 136–146.
  • Mishra, M. U.; Khandare, J. N. Evaluation of Tamarind Seed Polysaccharide as a Biodegradable Carrier for Colon Specific Drug Delivery. Int. J. Pharm. Pharm. Sci. 2010, 3, 139–142.
  • Pandit, A. P.; Waychal, P. D.; Sayare, A. S.; Patole, V. C. Carboxymethyl Tamarind Seed Kernel Polysaccharide Formulated into Pellets to Target at Colon. IJPER 2018, 52, 363–373. doi:10.5530/ijper.52.3.42.
  • Cortina, L. O.; Domenech, C. M. T. Analytical Characterization of Diterpenoid Resins Present in Pictorial Varnishes Using Pyrolysis-Gas Chromatography-Mass Spectrometry with on Line Trimethylsilylation. J. Chrom. A 2005, 1065, 265–278.
  • Shun, Y. L.; Ayres, J. W. Calcium Alginate Beads as Core Carriers of 5-Aminosalicylic Acid. Pharm. Res. 1992, 9, 714–790.
  • Umekar, M. J.; Yeole, P. G. Characterization and Evaluation of Natural Copal Gum-Resin as Film Forming Material. Int. J. Green Pharm. 2008, 2, 37–42. doi:10.4103/0973-8258.39163.
  • Mehboob, R.; Ramnath, A. A.; Satish, N. S.; Waghmode, C. Natural Polysaccharides as Drug Targeting Tool to Colon: Recent Applications and Future Prospective. Int. J. Pharm. Chem. Biol. Sci. 2015, 5, 440–455.
  • Singh, P. P.; Whistler, R. L.; Tokuzen, R.; Nakahara, W. Scleroglucan, an Antitumor Polysaccharide from Sclerotium Glucanicum. Carbohyd. Res. 1974, 37, 245–247. doi:10.1016/S0008-6215(00)87078-0.
  • Ates, O. Systems Biology of Microbial Exopolysaccharides Production. Front. Bioeng. Biotechnol. 2015, 3, 200–216. doi:10.3389/fbioe.2015.00200.
  • Lima, I. A.; Pomin, S. P.; Cavalcanti, O. A. Development and Characterization of Pullulan-Polymethacrylate Free Films as Potential Material for Enteric Drug Release. Braz. J. Pharm. Sci. 2017, 53, 1–9. doi:10.1590/s2175-97902017000300002.
  • Lee, S. J.; Hong, G.-Y.; Jeong, Y.-I.; Kang, M.-S.; Oh, J.-S.; Song, C.-E.; Lee, H. C. Paclitaxel-Incorporated Nanoparticles of Hydrophobized Polysaccharide and Their Antitumor Activity. Int. J. Pharm. 2012, 433, 121–128. doi:10.1016/j.ijpharm.2012.04.048.
  • Babu, R. J.; Sathigari, S.; Kumar, M. T.; Pandit, J. K. Formulation of Controlled Release Gellan Gum Macro Beads of Amoxicillin. Curr. Drug Deliv. 2010, 7, 36–43. doi:10.2174/156720110790396445.
  • Singh, B. N.; Trombetta, L. D.; Kim, K. H. Biodegradation Behavior of Gellan Gum in Simulated Colonic Media. Pharm. Dev. Technol. 2004, 9, 399–407. doi:10.1081/pdt-200035793.
  • Prezotti, F.; Boni, F.; Ferreira, N.; Silva, D.; Campana-Filho, S.; Almeida, A.; Vasconcelos, T.; Gremião, M.; Cury, B.; Sarmento, B. Gellan Gum/Pectin Beads Are Safe and Efficient for the Targeted Colonic Delivery of Resveratrol. Polymers 2018, 10, 50–14. doi:10.3390/polym10010050.
  • Prabhakar, P.; Nisssara, A.; Harish, N. M. Investigation of Colon Specificity of Novel Polymer Khaya Gum with Guar Gum. Pak. J. Pharm. Sci 2010, 23, 259–265.
  • Rana, V.; Rai, P.; Tiwary, A. K.; Singh, R. S.; Kennedy, J. F.; Knill, C. J. Modified Gums: Approaches and Applications in Drug Delivery. Carbohyd. Polym. 2011, 83, 1031–1047. doi:10.1016/j.carbpol.2010.09.010.
  • Talukdar, M. M.; Kinget, R. Swelling and Drug Release Behavior of Xanthan Gum Matrix Tablet. Int. J. Pharm. 1995, 120, 63–72. doi:10.1016/0378-5173(94)00410-7.
  • Musukula, Y. R. Evaluation of Compression Coated Colon Targeted Tablets of Ketorolac Tromithamine by Using Natural Polymer and Their Combination with HPMC K100M. Int. J. Res. Pharm. Nano. Sci. 2014, 3, 408–417.
  • Bharaniraja, B.; Kumar, K. J.; Prasad, C. M.; Sen, A. K. Different Approaches of Katira Gum Formulations for Colon Targeting. Int. J. Biol. Macromol. 2011, 49, 305–310. doi:10.1016/j.ijbiomac.2011.05.002.
  • Girotra, P.; Singh, S. K. Formulation Optimization for Colon Targeted Delivery of Katira Gum Matrix Tablets Containing Azathioprine. Int. J. Pharm. Sci. Drug. Res. 2013, 5, 133–140.
  • Ruhidas, B.; Naskar, D.; Banerjee, S.; Karan, S.; Chatterjee, T. K. Evaluation of Gum Katira as a Model Sustained Release Adjuvant in the Preparation of Etodolac Loaded Microsphere. IJPER 2016, 50, 146–158. doi:10.5530/ijper.50.1.19.
  • Karan, S.; Choudhury, H.; Chakra, B. K.; Chatterjee, T. K. Polymeric Microsphere Formulation for Colon Targeted Delivery of 5-Fluorouracil Using Biocompatible Natural Gum Katira. Asian Pac. J. Cancer Prev. 2019, 20, 2181–2194. doi:10.31557/APJCP.2019.20.7.2181.
  • Kavitha, R.; Krishna, M. G.; Satla, S.; Gaikwad, S. Natural Polysaccharides: Versatile Excipients for Controlled Drug Delivery Systems. Asian J. Pharm. Sci. 2011, 6, 275–286.
  • Jain, A.; Jain, S. K.; Ganesh, N.; Barve, J.; Beg, A. M. Design and Development of Ligand-Appended Polysaccharidic Nanoparticles for the Delivery of Oxaliplatin in Colorectal Cancer. Nanomedicine 2010, 6, 179–190. doi:10.1016/j.nano.2009.03.002.
  • Xiao, B.; Han, M. K.; Viennois, E.; Wang, L.; Zhang, M.; Si, X.; Merlin, D. Hyaluronic Acid-Functionalized Polymeric Nanoparticles for Colon Cancer-Targeted Combination Chemotherapy. Nanoscale 2015, 7, 17745–17755. doi:10.1039/c5nr04831a.
  • Xiao, B.; Xu, Z.; Viennois, E.; Zhang, Y.; Zhang, Z.; Zhang, M.; Han, M. K.; Kang, Y.; Merlin, D. Orally Targeted Delivery of Tripeptide KPV via Hyaluronic Acid-Functionalized Nanoparticles Efficiently Alleviates Ulcerative Colitis. Molecul. Therap. 2017, 25, 1628–1640. doi:10.1016/j.ymthe.2016.11.020.
  • Kalsoom Khan, A.; Saba, A. U.; Nawazish, S.; Akhtar, F.; Rashid, R.; Mir, S.; Nasir, B.; Iqbal, F.; Afzal, S.; Pervaiz, F.; Murtaza, G. Carrageenan Based Bionanocomposites as Drug Delivery Tool with Special Emphasis on the Influence of Ferromagnetic Nanoparticles. Oxid. Med. Cell. Long. 2017, 2017, 1–13. doi:10.1155/2017/8158315.
  • Chen, X.; Han, W.; Zhao, X.; Tang, W.; Wang, F. Epirubicin-Loaded Marine Carrageenan Oligosaccharide Capped Gold Nanoparticle System for pH-Triggered Anticancer Drug Release. Sci. Rep. 2019, 9, 1–10.
  • Kern, M.; Pahlke, G.; Balavenkatraman, K. K.; Böhmer, F. D.; Marko, D. Apple Polyphenols Affect Protein Kinase C Activity and the Onset of Apoptosis in Human Colon Carcinoma Cells. J. Agric. Food Chem. 2007, 55, 4999–5006. doi:10.1021/jf063158x.
  • Li, Y.; Liu, L.; Niu, Y.; Feng, J.; Sun, Y.; Kong, X.; Chen, Y.; Chen, X.; Gan, H.; Cao, S.; Mei, Q. Modified Apple Polysaccharide Prevents against Tumorigenesis in a Mouse Model of Colitis-Associated Colon Cancer: Role of Galectin-3 and Apoptosis in Cancer Prevention. Eur. J. Nutr. 2012, 51, 107–117. doi:10.1007/s00394-011-0194-3.
  • Zhang, D.; Li, Y-h.; Mi, M.; Jiang, F.-L.; Yue, Z-g.; Sun, Y.; Fan, L.; Meng, J.; Zhang, X.; Liu, L.; Mei, Q.-B. Modified Apple Polysaccharides Suppress the Migration and Invasion of Colorectal Cancer Cells Induced by Lipopolysaccharide. Nutr. Res. 2013, 33, 839–848. doi:10.1016/j.nutres.2013.06.004.
  • Thakral, S.; Thakral, N. K.; Majumdar, D. K. Eudragit: A Technology Evaluation. Exp. Opin. Drug Deliv. 2013, 10, 131–149. doi:10.1517/17425247.2013.736962.
  • Varshosaz, J.; Emami, J.; Tavakoli, N.; Minaiyan, M.; Rahmani, N.; Dorkoosh, F.; Mahzouni, P. Pectin Film Coated Pellets for Colon-Targeted Delivery of Budesonide: In-Vitro/In-Vivo Evaluation in Induced Ulcerative Colitis in Rat. Iran. J. Pharm. Res. 2012, 11, 733–745.
  • Kotagale, N.; Maniyar, M.; Somvanshi, S.; Umekar, M.; Patel, C. J. Eudragit-S, Eudragit-L and Cellulose Acetate Phthalate Coated Polysaccharide Tablets for Colonic Targeted Delivery of Azathioprine. Pharm. Dev. Technol. 2010, 15, 431–437. doi:10.3109/10837450903264401.
  • Akhgari, A.; Afrasiabi, G. H.; Sadeghi, F. Combination of Inulin and Time Dependent Polymethacrylates as a Coating System to Achieve Colonic Delivery of Indomethacin. DARU 2009, 17, 199–208.
  • Nath, B.; Nath, L. K. Design, Development, and Optimization of Sterculia Gum-Based Tablet Coated with Chitosan/Eudragit RLPO Mixed Blend Polymers for Possible Colonic Drug Delivery. J. Pharmaceutic 2013, 2013, 1–9. doi:10.1155/2013/546324.
  • Wang, X.; Yu, D. G.; Li, X. Y.; Bligh, S. W.; Williams, G. R. Electrospun Medicated Shellac Nanofibers for Colon-Targeted Drug Delivery. Int. J. Pharm. 2015, 490, 384–390. doi:10.1016/j.ijpharm.2015.05.077.
  • Ravi, V.; Kumar, P.; Siddaramaiah, T. M. Novel Colon Targeted Drug Delivery ++ System Using Natural Polymers. Indian J. Pharm. Sci. 2008, 70, 111–113.
  • Gately, N. M.; Kennedy, J. E. The Development of a Melt-Extruded Shellac Carrier for the Targeted Delivery of Probiotics to the Colon. Pharmaceutic 2017, 9, 1–12.
  • Oehme, A.; Valotis, A.; Krammer, G.; Zimmermann, I.; Schreier, P. Preparation and Characterization of Shellac-Coated Anthocyanin Pectin Beads as Dietary Colonic Delivery System. Mol. Nutr. Food Res. 2011, 55, S75–S85. doi:10.1002/mnfr.201000467.
  • Liu, D.; Yan, H.; Kong, Y.; You, Y.; Li, Y.; Wang, L.; Tong, Y.; Wang, J. Preparation of Colon-Targeted Acetylharpagide Tablets and Its Release Properties In Vivo and In Vitro. Front. Pharmacol. 2018, 9, 1–9. doi:10.3389/fphar.2018.00832.
  • Paradkar, M.; Amin, J. Formulation Development and Evaluation of Colon Targeted Delayed Release Methotrexate Pellets for the Treatment of Colonic Carcinoma. Braz. J. Pharm. Sci. 2018, 54, 1–12. doi:10.1590/s2175-97902018000417222.
  • Emeje, M.; Nwabunike, P.; Isimi, Y.; Kunle, O.; Ofoefule, S. Preparation and Evaluation of Colon Targeted Drug Delivery Systems for Albendazole Using Kneading, Extrusion and Compaction Technology. Acta. Pharm. Sinic. 2009, 44, 1152–1158.
  • Ganguly, K.; Aminabhavi, T. M.; Kulkarni, A. R. Colon Targeting of 5-Fluorouracil Using Polyethylene Glycol Cross-Linked Chitosan Microspheres Enteric Coated with Cellulose Acetate Phthalate. Ind. Eng. Chem. Res. 2011, 50, 11797–11807. doi:10.1021/ie201623d.
  • Dang, T.; Cui, Y.; Chen, Y. D.; Meng, X. M.; Tang, B. F.; Wu, J. B. Preparation and Characterization of Colon-Specific Microspheres of Diclofenac for Colorectal Cancer. Trop. J. Pharm. Res. 2015, 14, 1541–1547.
  • Yus, C.; Gracia, R.; Larrea, A.; Andreu, V.; Irusta, S.; Sebastian, V.; Mendoza, G.; Arruebo, M. Targeted Release of Probiotics from Enteric Microparticulated Formulations. Polymer 2019, 11, 1–14.
  • Trenktrog, T.; Müller, B. W.; Specht, F. M.; Seifert, J. Enteric Coated Insulin Pellets: Development, Drug Release and In Vivo Evaluation. Eur. J. Pharm. Sci. 1996, 4, 323–329. doi:10.1016/0928-0987(95)00162-X.
  • Das, M.; Ghosh, L. Evaluation of Polymer for Compression Coating of 5-Aminosalicylic Acid Matrix Tablet for Colon Targeting. Int. J. Pharm. Pharm. Sci. 2013, 5, 975–1491.
  • Koch, W. Properties and Uses of Ethylcellulose. Ind. Eng. Chem. 1937, 29, 687–690. doi:10.1021/ie50330a020.
  • Ahrabi, S. F.; Madsen, G.; Dyrstad, K.; Sande, S. A.; Graffner, C. Development of Pectin Matrix Tablets for Colonic Delivery of Model Drug Ropivacaine. Eur. J. Pharm. Sci. 2000, 10, 43–52. doi:10.1016/S0928-0987(99)00087-1.
  • Gohel, M. C.; Nagori, S. A. A Novel Colonic Drug Delivery System of Ibuprofen. Asian J. Pharm. 2009, 3, 233–239. doi:10.4103/0973-8398.56304.
  • Sheskey, P. J.; Cook, W. G.; Cable, C. G. Handbook of Pharmaceutical Excipients, 8th ed.; London: Pharmaceutical Press, 2017; pp 191–193
  • Pawar, P. S.; Saleem, M. A. Formulation and Evaluation of Oral Colon Targeted Tablet of Budesonide. Der. Pharmacia. Lettre 2013, 5, 1–12.
  • Shah, N.; Shah, T.; Amin, A. Polysaccharides: A Targeting Strategy for Colonic Drug Delivery. Exp. Opin. Drug Deliv. 2011, 8, 779–796. doi:10.1517/17425247.2011.574121.
  • Patel, M. M. Cutting-Edge Technologies in Colon-Targeted Drug Delivery Systems. Exp. Opin. Drug Deliv. 2011, 8, 1247–1258. doi:10.1517/17425247.2011.597739.
  • Charbe, N. B.; McCarron, P. A.; Lane, M. E.; Tambuwala, M. M. Application of Three-Dimensional Printing for Colon Targeted Drug Delivery Systems. Int. J. Pharm. Investig. 2017, 7, 47–59. doi:10.4103/jphi.JPHI_32_17.
  • Zhang, T.; Zhu, G.; Lu, B.; Peng, Q. Oral Nano-Delivery Systems for Colon Targeting Therapy. Pharm. Nanotechnol. 2017, 5, 83–94. doi:10.2174/2211738505666170424122722.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.